Related Experiment Video
Updated: Feb 28, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Acute liver injury in a Glatopa-treated patient with MS
Joseph J Sabatino1, Neil J Mehta1, Sanjay Kakar1
1Multiple Sclerosis Center (J.J.S., S.S.Z., B.A.C.C.), Department of Neurology, Division of Gastroenterology (N.J.M.), Department of Medicine, and GI-Hepatobiliary Pathology Service (S.K.), Department of Pathology, University of California San Francisco.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

